Allogeneic γ9δ2 T Cells Treatment of Recurrent Hematologic Tumors

NCT05755854 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

10

Enrollment

OTHER_GOV

Sponsor class

Conditions

Hematologic Diseases

Interventions

BIOLOGICAL: allogeneic γ9δ2 T Cells
DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: Zoredronic acid

Sponsor

Anhui Provincial Hospital